A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control
Barry L Carter, George R Bergus, Jeffrey D Dawson, Karen B Farris, William R Doucette, Elizabeth A Chrischilles, Arthur J Hartz, Barry L Carter, George R Bergus, Jeffrey D Dawson, Karen B Farris, William R Doucette, Elizabeth A Chrischilles, Arthur J Hartz
Abstract
This was a prospective, cluster randomized controlled trial in patients with uncontrolled hypertension aged 21 to 85 years (mean, 61 years). Pharmacists made recommendations to physicians for patients in the intervention clinics (n=101) but not patients in the control clinics (n=78). The mean adjusted difference in systolic blood pressure (BP) between the control and intervention groups was 8.7 mm Hg (95% confidence interval [CI], 4.4-12.9), while the difference in diastolic BP was 5.4 mm Hg (CI, 2.8-8.0) at 9 months. The 24-hour BP levels showed similar effects, with a mean systolic BP level that was 8.8 mm Hg lower (CI, 5.0-12.6) and a mean diastolic BP level that was 4.6 mm Hg (CI, 2.4-6.8) lower in the intervention group. BP was controlled in 89.1% of patients in the intervention group and 52.9% in the control group (adjusted odds ratio, 8.9; CI, 3.8-20.7; P<.001). Physician/pharmacist collaboration achieved significantly better mean BP values and overall BP control rates, primarily by intensification of medication therapy and improving patient adherence.
Trial registration: ClinicalTrials.gov NCT00201045.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8110039/bin/JCH-10-260-g001.jpg)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8110039/bin/JCH-10-260-g002.jpg)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8110039/bin/JCH-10-260-g003.jpg)
Source: PubMed